Orally disintegrating systems: innovations in formulation and technology
- PMID: 19075912
- DOI: 10.2174/187221108786241660
Orally disintegrating systems: innovations in formulation and technology
Abstract
Orally disintegrating systems have carved a niche amongst the oral drug delivery systems due to the highest component of compliance they enjoy in patients especially the geriatrics and pediatrics. In addition, patients suffering from dysphagia, motion sickness, repeated emesis and mental disorders prefer these medications because they cannot swallow large quantity of water. Further, drugs exhibiting satisfactory absorption from the oral mucosa or intended for immediate pharmacological action can be advantageously formulated in these dosage forms. However, the requirements of formulating these dosage forms with mechanical strength sufficient to with stand the rigors of handling and capable of disintegrating within a few seconds on contact with saliva are inextricable. Therefore, research in developing orally disintegrating systems has been aimed at investigating different excipients as well as techniques to meet these challenges. A variety of dosage forms like tablets, films, wafers, chewing gums, microparticles, nanoparticles etc. have been developed for enhancing the performance attributes in the orally disintegrating systems. Advancements in the technology arena for manufacturing these systems include the use of freeze drying, cotton candy, melt extrusion, sublimation, direct compression besides the classical wet granulation processes. Taste masking of active ingredients becomes essential in these systems because the drug is entirely released in the mouth. Fluid bed coating, agglomeration, pelletization and infusion methods have proven useful for this purpose. It is important to note that although, freeze dried and effervescent disintegrating systems rapidly disintegrate in contact with fluids, they do not generally exhibit the required mechanical strength. Similarly, the candy process cannot be used for thermolabile drugs. In the light of the paradoxical nature of the attributes desired in orally disintegrating systems (high mechanical strength and rapid disintegration), it becomes essential to study the innovations in this field and understand the intricacies of the different processes used for manufacturing these systems. This article attempts at discussing the patents relating to orally disintegrating systems with respect to the use of different formulation ingredients and technologies.
Similar articles
-
Oral Disintegrating Tablets - An Updated Patent Perspective.Recent Pat Drug Deliv Formul. 2020;14(3):166-190. doi: 10.2174/1872211314999201123202930. Recent Pat Drug Deliv Formul. 2020. PMID: 33231150 Review.
-
The technologies used for developing orally disintegrating tablets: a review.Acta Pharm. 2011 Jun;61(2):117-39. doi: 10.2478/v10007-011-0020-8. Acta Pharm. 2011. PMID: 21684842 Review.
-
Formulation and in vitro evaluation of ketoprofen fast-dissolving tablets.Pharm Dev Technol. 2016 Dec;21(8):901-908. doi: 10.3109/10837450.2015.1022792. Epub 2015 Mar 23. Pharm Dev Technol. 2016. PMID: 25798913
-
Comprehensive review on oral disintegrating films.Curr Drug Deliv. 2013 Feb;10(1):96-108. doi: 10.2174/1567201811310010016. Curr Drug Deliv. 2013. PMID: 22920576 Review.
-
Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies.Crit Rev Ther Drug Carrier Syst. 2004;21(6):433-76. doi: 10.1615/critrevtherdrugcarriersyst.v21.i6.10. Crit Rev Ther Drug Carrier Syst. 2004. PMID: 15658933 Review.
Cited by
-
Characterization and in vivo efficacy of a heptapeptide ODT formulation for the treatment of neurogenic bladder dysfunction.Int J Pharm. 2018 Jan 30;536(1):397-404. doi: 10.1016/j.ijpharm.2017.11.036. Epub 2017 Nov 28. Int J Pharm. 2018. PMID: 29195918 Free PMC article.
-
Overcoming Poor Solubility of Dimenhydrinate: Development, Optimization and Evaluation of Fast Dissolving Oral Film.Adv Pharm Bull. 2018 Nov;8(4):721-725. doi: 10.15171/apb.2018.081. Epub 2018 Nov 29. Adv Pharm Bull. 2018. PMID: 30607345 Free PMC article.
-
Orally disintegrating films: A modern expansion in drug delivery system.Saudi Pharm J. 2016 Sep;24(5):537-546. doi: 10.1016/j.jsps.2015.02.024. Epub 2015 Mar 10. Saudi Pharm J. 2016. PMID: 27752225 Free PMC article. Review.
-
Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve Paediatric Patient's Compliance.AAPS PharmSciTech. 2024 Apr 8;25(4):79. doi: 10.1208/s12249-024-02796-9. AAPS PharmSciTech. 2024. PMID: 38589718
-
Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors.Front Pharmacol. 2018 Feb 6;9:59. doi: 10.3389/fphar.2018.00059. eCollection 2018. Front Pharmacol. 2018. PMID: 29467656 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical